PATENT CLAIM ANALYSIS

Application Number: 16115350
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-05
Patent Classification: ["424", "204100"]

Abstract:
The invention relates to methods of assessing a patient's risk of developing Progressive multifocal leukoencephalopathy (PML).

Claim (Index 28):
The method of  claim 22 , wherein the subject has been free of a non-anti-VLA-4 immunosuppressant therapy for the lifetime of the subject.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 96.0
- Lexical Diversity: 1.05263
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14893989', '13521311', '15063777', '14234065', '15106074']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7114410101405354
- 35 USC 102 Novelty (BERT): 0.6060591673423772
- Combined Prediction Score: 0.7009028258607196
- Mean Citation Score: 380.26623
- Max Citation Score: 591.05133
- Similarity Product: 432.9643091147232

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test